Round voting button logo

H.R.8260

Cardiovascular Disease Early Detection and Prevention Act of 2026

Introduced·4/14/26

Cardiovascular Disease Early Detection and Prevention Act of 2026 mandates coverage of lipoprotein(a) and apolipoprotein B tests without cost sharing.

The Cardiovascular Disease Early Detection and Prevention Act of 2026 aims to improve cardiovascular health by requiring coverage of specific tests without cost sharing. It mandates that group health plans, individual health insurance, Medicare, and Medicaid cover lipoprotein(a) and apolipoprotein B tests for individuals with a family history of premature cardiovascular disease, a personal history of myocardial infarction, stroke, or elevated LDL cholesterol, a diagnosis of diabetes mellitus or obesity, or other recognized cardiovascular risk factors.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Energy And Commerce Committee
Next
Committee decision

Sponsors

D
1
0
Democratic CaucusRepublican Caucus

History

Apr 14

House

Introduced in House

Apr 14

House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.